BCL2 and acute lymphoblastic leukemia: Chonghaile et al. used BH-3 profiling in various T-ALL cell lines and primary cells and showed a dependence on BCL-XL, with a higher sensitivity to navitoclax that inhibits BCL-XL and BCL-2 compared to the more selective venetoclax.